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INTRODUCTION
Alexander disease (AD) is a fatal and progressive leukodys-
trophy of the central nervous system. The destruction of white
matter in a rostrocaudal gradient is accompanied by the accu-
mulation of abnormal deposits, known as Rosenthal fibers
(RFs), in astrocytes, which result in cell death.
The clinical phenotype of AD has been divided into three
types based on age at onset, i.e., infantile, juvenile, and adult
AD. However, clinically the disease is highly variable among
patients in the same disease group. Typical features of the in-
fantile form occur before 2 yr old, and present as progressive
macrocephaly, developmental delay, spasticity, and seizures.
Seizure is a common clinical symptom in AD, but infantile
spasms are a less well-known manifestation. Brain magnetic
resonance imaging (MRI) reveals predominantly frontal white
matter involvement of low signal intensity on T1-weighted
images and high signal intensity on T2-weighted images. 
Since Brenner et al. (1) discovered a missense mutation in
glial fibrillary acidic protein (GFAP) gene in chromosome 17th
in AD, DNA analysis has proven to be a valuable diagnostic
modality. 
CASE REPORT
An 8-month-old boy (Fig. 1A, B) was admitted to our emer-
gency room because of repeated seizures. A seizure had occurr-
ed a day prior to this presentation. It persisted for 30 min,
and his parents observed upward eyeball fixation and tonic-
clonic movement of the extremities. However, treatment was
not sought at the time. At his home on the day of this hospi-
talization, a seizure redeveloped, persisted for about an hour
and then spontaneously stopped. Several hours later the third
seizure occurred and did not stop. His parents then brought
the patient to our emergency room where the seizure was
observed by doctors. Pupils were fixed without deviation with
nictitating of eyelids, lip smacking, and stiffness of the right
extremities. The seizure stopped after a diazepam injection.
Subsequently, seizures were controlled by valproic acid admin-
istration. 
The patient had no relevant birth or family history. At the
time of hospitalization, his body temperature was 36.6℃,
pulse rate 128/min, and respiratory rate 28/min. In terms of
body measurements, his body weight was 8.8 kg (20th per-
centile), height 75 cm (90th percentile), and head circumfer-
ence 51 cm (more than the 97th percentile). Anterior fontanel
was soft and flat, and he had macrocephaly and a projecting
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A Case of Infantile Alexander Disease Accompanied by Infantile
Spasms Diagnosed by DNA Analysis 
Alexander disease (AD) is a rare leukodystrophy of the central nervous system of
unknown etiology. AD is characterized by progressive failure of central myelination
and the accumulation of Rosenthal fibers in astrocytes, and is inevitably lethal in
nature. Symptomatically, AD is associated with leukoencephalopathy with macro-
cephaly, seizures, and psychomotor retardation in infants, and usually leads to death
within the first decade. Its characteristic magnetic resonance imaging (MRI) findings
have been described as demyelination predominantly in the frontal lobe. Moreover,
dominant mutations in the GFAP gene, coding for glial fibrillary acidic protein (GFAP),
a principal astrocytic intermediate filament protein, have been shown to lead to AD.
The disease can now be detected by genetic diagnosis. We report the Korean case
of an 8-month-old male patient with AD. He was clinically characterized due to the
presence of psychomotor retardation, megalencephaly, spasticity, and recurrent
seizures including infantile spasms which is a remarkable presentation. Demyeli-
nation in the frontal lobe and in a portion of the temporal lobe was demonstrated
by brain MRI. Moreover, DNA analysis of peripheral blood showed the presence
of a R239L mutation in the GFAP gene, involving the replacement of guanine with
thymine.
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forehead, similar to that observed in hydrocephalus. Breath-
ing sounds were clear and heart beat regular. Liver and spleen
were not palpable and bowel sounds were normal. Light reflex
was isocoric and prompt, and deep tendon reflexes were in-
creased. Babinski sign was unremarkable and both ankles
showed clonus. He was unable to control his head, and his
language and social skills were at the 1-2 month post-natal
level. 
The complete blood count was within normal limits, and
total protein/albumin was 6.2/4.3 g/dL, Na/K/Cl 138/4.9/
104 mEq/L, blood sugar 100 mg/dL, BUN/Cr 11/0.4 mg/
dL, and AST/ALT 26/22 IU/L, respectively. Normal finding
was seen by 7.93 (4.9-20.5 mM/M creatinine) in N-acety-
laspartic acid (NAA) of urine. Brain MRI showed an absence
of myelination except in the frontal lobe and in a portion of
the temporal lobe (Fig. 2A, B). DNA analysis revealed that
the 716th base sequence of the 4th exon of the GFAP gene
showed thymine substituted for guanine (c.716G>T), which
led to R239L missense mutation at the 239th amino acid
involving the replace of arginine by leucine. Additionally,
when we examined the DNA of his parents and older sister,
it appeared that they had a normal base sequence (Fig. 3). Inter-
ictal waking electroencephalography (EEG) showed slow waves
in the frontal lobe, but no epileptic discharge (Fig. 4A). 
Three months later, at the age of 11 months, infantile spasms
of the flexor type developed accompanied with vocalization
Fig. 1. General appearance (A) and traction response (B) of the
patient at the age of 8 months on admission are compared with
(C) and (D) at the age of 20 months.
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Fig. 2. MRI reveals regions with decreased signal in the bilateral
frontal white matter on T1-weighted imagies (A) and high signal
intensity on T2-weighted images (B) mainly on the frontal lobe. MRI
reveals regions with more decreased signal in the bilateral frontal
white matter on T1-weighted imagies(C) and higher signal inten-
sity on T2-weighted images (D) than previous MRI and decreased
volume in both frontal white matter. 
A B
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Fig. 4. Interictal EEG shows focal slowing on the frontal lobe
mixed with fast beta waves at the age of 8 months (A). Interictal
EEG shows asynchronous high voltage multifocal spikes at the
age 20 months (B). 
Fig. 3. Identification of the GFAP gene mutation. Direct sequenc-
ing analysis of the patient and his family members demonstrates
a de novo R239L mutation due to a G to T transversion (c.716G>T;
arrow) in exon 4 of the GFAP gene. 
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after waking up. Interictal sleep EEG showed hypsarrythmia
(Fig. 4B). The spasms came under control after starting viga-
batrin (40 mg/kg/day) and after the third day of this medica-
tion, no more spasm was observed. A follow-up MRI at 24
months of age showed disease progression (Fig. 2C, D).
Now, at age 30 months (Fig. 1C, D), he is in good nutri-
tional condition and has a relatively good cardiopulmonary
function. However, he suffers from intermittent vomiting,
dysphagia, irritability, easy startling, developmental retar-
dation, slow progressive spasticity of the extremities, and
seizures.
DISCUSSION
W. Stewart Alexander, in his original description of a case
in 1949 (2), reported a boy with a rapidly enlarging head,
hydrocephalus, and developmental delay who died at 15 mon-
ths of age following an 8-month illness. AD is a progressive
and usually fatal neurological disorder in which the destruc-
tion of white matter in the brain (3, 4). However, little infor-
mation is available on the pathogenesis of AD, or on how
the GFAP mutation leads to leukodystrophy (5, 6). 
In 1976, Russo et al. (7) suggested that AD could be divid-
ed into three age-dependent clinical subgroups: infantile,
juvenile, and adult and most authors have adopted this clas-
sification. However, the clinical picture is highly variable
among patients in the same subgroup. The infantile form of
AD is most common (8-11), and usually becomes apparent
during the first two years of life. Typically patients show both
mental and physical developmental delays, followed by loss
of milestones, an abnormal increase in head size, and often
seizures. The average age of onset is 6 months and the aver-
age age of survival after diagnosis is 2 yr and 4 months. But
Wakabayashi et al. (12) reported a Japanese case of infantile
AD who survived at the age of 25 yr and 7 months. Thus, the
clinical progress in AD may be varied by case.
In our patient, although seizure occurred at age 8 months,
we suggest that clinical manifestations had developed before
at least age 3 months because he was unable to control his
head at age 4 months. According to Pridmore et al. (13),
seizures often appear at an early stage, whereas spastic quadri-
paresis is less prominent and occurs later. Macrocephaly is a
presenting feature due to rapid head enlargement followed
by deceleration. Our patient showed prominent macrocephaly,
and developmental retardation before the seizure attacks which
occurred at age 8 months. We initially observed slow waves
on the frontal area on interictal sleep EEG, but there was no
epileptic discharge (Fig. 4A). Three months later, at age 11
months, infantile spasms developed after waking up. An inter-
esting finding of typical hypsarrythmia on interictal sleep
EEG (Fig. 4B) was observed. These findings suggested that
infantile spasms developed during AD progression. Infantile
spasms in AD cases are a remarkable presentation, and are
rare according to many reports. Although Gingold et al. (14)
described briefly that his AD patient developed multifocal
seizures at age 11 months and EEG demonstrated hypsar-
rhythmia, which was recorded at the left posterior hemisphere
during an ictal episode, no further description was provided.
They first described an AD case accompanied by infantile
spasms, and since no further cases have been published, our
case is the second, which is why we consider this case valu-
able. We controlled these infantile spasms with vigabatrin,
which has a highly effective anticonvulsant action. 
A definitive diagnosis was only possible by pathological
examination of brain tissue, obtained either at biopsy or au-
topsy, for RFs until the genetic diagnostic method became
available. Biochemical studies on compositions of RFs revealed
that a large portion of the fibers consisted of the heat shock
protein,  B-crystallin (15), and lesser amounts of heat shock
protein 27 and ubiquitin (16). Brain MRI is a helpful diag-
nostic method. In AD, brain white matter degeneration app-
ears remarkably in the frontal lobe on MRI and hydrocephalus
occurs infrequently (17, 18).
GFAP was found to be distributed much more on astroglial
cell channels comprised of intermediate filaments of diame-
ter 7-11 nm and codes by gene 17q21’s GFAP gene. AD can
now be diagnosed in a high percentage of cases by analyzing
DNA obtained from peripheral blood, which obviates the
need for brain biopsy. Brenner et al. (1) sequenced the GFAP
coding region in the DNA from 11 unrelated patients who
had died of AD and discovered that 10 patients had muta-
tions in the GFAP coding region. Four different GFAP amino
acid mutations were observed in this initial group of patients.
Li et al. (19) analyzed the DNA of 44 AD cases and found a
GFAP gene mutation in 41 cases. Moreover, as studied paren-
tal DNAs have also failed to reveal such mutations, it must
be presumed that they are wholly spontaneous in nature. This
indicates that AD is not autosomal recessive, as had previously
been thought by Wohlwill et al. (20) and Schwankhaus et al.
(21), but that it is possibility due to a gonadal mosaicism.
In our patient, the R239L GFAP gene mutation (Fig. 3)
in which 716th base sequence of 4th exon showed a guanine
to thymine substitution (c.716G>T), and as a result, the
239th amino acid of GFAP is changed from arginine to leu-
cine. This was determined by conducting direct base sequence
analysis after amplifying all exons and intron regions of the
GFAP gene by PCR from peripheral blood genomic DNA.
However, the patient’s parents and older sister had a normal
base sequence. In addition, the position of the GFAP gene
mutation in AD which found up-to-date differs from this
case. Therefore, the R239L GFAP gene mutation in the pre-
sent case is presumed to be a de novo mutation or gonadal
mosaicism.
In conclusion, the authors report a rare case of AD accom-
panied by infantile spasms that was diagnosed by GFAP gene
analysis in an 8-month-old male with seizures, psychomotor
developmental retardation, macrocephaly, and spasticity ofInfantile Alexander Disease Diagnosed by DNA Analysis 957
the extremities. This DNA analysis performed identified a
novel R239L missense mutation. 
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